Mitesco (MITI) Cash from Discontinued Operations (2015 - 2023)

Mitesco (MITI) posted quarterly Cash from Discontinued Operations of 268566.0 for Q4 2023, up 20.04% quarter-over-quarter from 335881.0 in Q3 2023.

Mitesco (MITI) Cash from Discontinued Operations (2015 - 2023) Analysis & Trends

Mitesco (MITI) has reported Cash from Discontinued Operations for 2 consecutive years, with 268566.0 the latest figure, recorded in Q4 2023.

In Q4 2023, Cash from Discontinued Operations changed N/A year-over-year to 268566.0; the TTM figure through Sep 2024 stood at 268566.0 (up 47.95% YoY), while the FY2023 annual figure was 698611.0, up 82.84% from the prior year.
Cash from Discontinued Operations climbed to 268566.0 in Q4 2023 per MITI's latest filing, from 335881.0 in the prior quarter.
Across five years, Cash from Discontinued Operations topped out at 302802.0 in Q1 2023 and bottomed at 396966.0 in Q2 2023.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Cash from Discontinued Operations (Qtr)
1	Veeva Systems	39.72 Bn	32.40 Bn	662.02 Mn	-
2	BrightSpring Health Services	12.19 Bn	11.64 Bn	492.75 Mn	-
3	Healthequity	8.79 Bn	8.52 Bn	256.31 Mn	-
4	10x Genomics	7.31 Bn	6.76 Bn	112.50 Mn	-
5	Hinge Health	7.10 Bn	6.71 Bn	183.95 Mn	-
6	MiniMed	5.66 Bn	5.36 Bn	480.00 Mn	-
7	Waystar Holding	4.76 Bn	4.56 Bn	221.99 Mn	-
8	Doximity	4.46 Bn	3.77 Bn	132.93 Mn	-
9	Heartflow	3.66 Bn	3.28 Bn	53.19 Mn	-
10	Mitesco	533,866.19	532,333.19	-	-

Download Data